Archives

All posts by Cited in article

A campaign to get a ballot measure in front of Florida voters to legalize recreational marijuana in 2020 was announced Thursday. It is backed by MedMen, one of the US cannabis industry’s largest companies. The Adult Use of Marijuana initiative would give the go-ahead to adults 21 years and older to buy and possess up to 2.5 ounces of cannabis.

The measure will be promoted via the dispensary chain’s “Make it Legal Florida” political committee, which was registered earlier this month. But it is not unopposed—the effort will face competition from “Sensible Florida,” a campaign started to thwart the proposed ballot measure.

The measure would not explicitly allow Floridians to grow their own cannabis for recreational use. That’s to be expected from MedMen, which was part of the New York Medical Cannabis Industry Association when the group sent a memo to Governor Cuomo last December claiming that home grow operations encouraged illegal sales, and put cannabis users in danger by making it difficult to monitor pesticide content. (MedMen was subsequently booted from the association over allegations of sexist and racist comments and financial misdeeds by company leaders.)

MedMen currently has a medical marijuana dispensary in Florida’s West Palm Beach, and

Read More Here…

Crohn’s disease is an autoimmune disease that causes severe irritation and inflammation in the digestive tract. A form of inflammatory bowel disease (IBD), the condition often develops in young adults between the ages of 20 and 29 and has no known cure.

Complications from Crohn’s disease include intestinal obstruction or fistulas, abscesses, ulcers, and ultimately malnutrition as the body is not receiving adequate nutrients. Prescription medications are frequently used to treat Crohn’s patients, but they come with a host of side effects, such as chronic pain and respiratory infection.

Cannabis has demonstrated effectiveness in treating other autoimmune diseases, such as lupus and rheumatoid arthritis, but could it provide the same advantages to patients with Crohn’s disease?

– Read the entire article at Bezinga.

Read More Here…

A new law going into effect later this month will protect the rights of medical marijuana patients and establish regulations for the state’s fledgling medicinal cannabis industry. House Bill 2612, or the Oklahoma Medical Marijuana and Patient Protection Act, as the measure is also known, will go into effect on Friday, August 30.

Oklahoma lawmakers passed House Bill 2612 earlier this year to establish regulations after the medicinal use of cannabis was legalized by voters with the passage of State Question 788 in June 2018. Seen as a compromise between lawmakers intent on regulating the industry and patient advocates who campaigned for the constitutional amendment initiative, the Medical Marijuana and Patient Protection Act has also been referred to as the Unity Bill.

The measure enacts regulations for medical marijuana providers including packaging and labeling requirements. The new law also protects patient access by prohibiting strict requirements such as a ban on smokable cannabis flower or limits on the amount of THC in medical marijuana products.

Bill Protects Patients’ Jobs

House Bill 2612 also has employment protections for medical marijuana patients, including a ban on firing an employee or refusing to hire an applicant based “solely on the basis of a

Read More Here…

Over the last couple years, medical marijuana in Utah has been a hot and controversial subject. In what has become a protracted, back-and-forth process between state legislators, medical marijuana advocates, and other powerful players in the state, Utah’s medical marijuana program continues to undergo dramatic changes.

Now, state lawmakers are preparing to make another significant change. Specifically, they said they will soon eliminate a proposal to distribute medical cannabis through state and county health departments. Instead, medical marijuana in the state will be sold through a network of privately owned and operated dispensaries.

New Changes to Utah’s Medical Marijuana Program

As reported by local news source Fox 13 Salt Lake City, lawmakers are set to introduce the new change in a special session of the State Legislature.

Importantly, this change will overhaul the state’s planned system for distributing medical marijuana. Up until now, the state planned on using a “central fill” system. In this framework, all medical marijuana would be distributed and sold through state and local health departments.

The plan sparked controversy when it was passed at the end of 2018. Specifically, many medical marijuana advocates pointed out that the program would run into problems, as it essentially forces

Read More Here…

From Washington to main street, changes to U.S. drug policy are evident. CBD products line the aisles at supermarkets and convenience stores. And emboldened by a new law that permits hemp cultivation, states across America are considering the crop as a new agricultural cornerstone.

Those changes do not, however, extend to the U.S. military. The Department of Defense issued a stern warning to its servicemembers this week: steer clear of hemp-derived products such as cannabidiol, better known as CBD.

“It’s completely forbidden for use by any service member in any of the services at this point of time,” said Patricia Deuster, director of the Human Performance Laboratory at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, as quoted by Military.com.

The warning comes on the heels of similar guidelines issued by the nation’s sea services, with the Navy, Coast Guard and Marines all warning members that, despite changes to state and federal law, the military policy remains the same.

The need to clarify the policy stems in part from the Agriculture Improvement Act, better known as the 2018 Farm Bill, which legalized the regulated industrial production of hemp, a move that inspired several states to pursue cultivation

Read More Here…

NYSE-traded cannabis company Aphria Inc. (NYSE: APHA) (TSX:APHA) and ParcelPal Technology Inc. (CSE: PKG) (OTC: PTNYF) will be announcing later today a strategic partnership for the delivery of the former’s medical cannabis products.

According to information procured exclusively, ahead of a press release hitting the wire later today, distribution and delivery will commence in Calgary, Alberta, but expansion into other areas is expected to follow shortly. Aphria will be providing the cannabis products and online point of sale, while ParcelPal will be in charge of distribution, leveraging its delivery apps. Patients will also be able to track their deliveries in real time.

– Read the entire article at Forbes.

Read More Here…

She was only going from a CBD-legal country to a CBD-legal state to hang out at her friend’s cabin, but a Canadian woman unknowingly put her lifetime ability to enter the United States in question over a small bottle of CBD oil she carries around for scoliosis pain.

“I’m still really not sure what’s going to happen,” said the woman, who asked to remain anonymous until her application for re-entry is resolved. “It’s an issue I don’t want to follow me around my whole life.”

But it very well might. Last weekend she was passing through border inspection in Blaine, Washington, when she was pulled over and asked by an officer if she was carrying any “leafy greens.”

“I said no because, to me, ‘leafy greens’ is like marijuana, the actual bud, things that you smoke, recreational drugs,” she told a reporter from CBC News. “I use CBD daily and it’s not psychoactive, it can’t get me high at the dosage that I’ve been told to take it at.”

Now she must fill out a $600 application for re-entry — which she may have to re-submit every few years in perpetuity — that includes a criminal background check, letters of

Read More Here…

Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into an agreement with Cannamedical Pharma GmbH (“Cannamedical”) through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”), to export a wholesale shipment of $3.3 (€3) million worth of medical cannabis from Portugal to Germany. The shipment, which is expected to be completed in fall 2019, will be Tilray’s first from its state-of-the-art EU campus in Portugal to supply patients in Germany.

“This is a significant milestone for Tilray as we ramp up our capacity to serve international markets and generate revenue from our EU campus through the end of 2019,” says Tilray CEO Brendan Kennedy. “We believe our 2.5 million square feet of cultivation and state-of-the-art processing space in Europe is an important differentiator, which will enable us to reduce costs and improve margins while hedging against regulatory risk.”

– Read the entire article at Financial Post.

Read More Here…

A court in Mexico has ruled that two people should be allowed to legally use cocaine for recreational purposes, according to media reports. Under the ruling from a judge in Mexico City, the two unnamed people will be allowed to “possess, transport, and use cocaine” although they will not be permitted to sell the drug, according to representatives of the group Mexico United Against Crime (MUCD).

Legal papers were filed in the case by MUCD on behalf of the two people as part of a strategy to reform Mexico’s prohibitionist drug laws and improve public safety. After the ruling, the group said the case signals a new stage in the understanding of drugs by the Mexican judiciary and offers an opportunity to end the country’s War on Drugs.

“We have spent years working for a more secure, just, and peaceful Mexico,” said Lisa Sánchez, MUCD’s director.

“This case is about insisting on the need to stop criminalizing users of drugs… and design better public policies that explore all the available options, including regulation.”

Judge’s Ruling to be Reviewed by Higher Court

The judge’s ruling directs Mexico’s national health department, Cofepris, to authorize the two unidentified persons to possess, transport, and

Read More Here…

For the fourth year in a row, Calgary will be going to pot during the second weekend in October for the Hempfest Cannabis Expo.

This year’s expo, the first since legalization in October 2018, will feature Canada’s first legal cannabis competition, the Hempfest Cup, and organizers’ expectations are high.

“What we’re kinda going after is something like the SIP awards in the liquor industry, where craft alcohol producers can send in a bottle and be judged, so that’s what it’s trying to model,” expo organizer Sacha Hockenhull said. “Cannabis producers can now enter a competition that ranks them against each other.”

The competition, which will run alongside the expo on Oct. 11 and 12 at the Big Four building at Stampede Park, is open to any Canadian who can legally grow cannabis, from personal-use growers to licensed producers (LP).

– Read the entire article at Calgary Herald.

Read More Here…